SEP 9, 2026 · PHASE 3 TRIAL
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
ClinicalTrials.gov
This is an active clinical trial registry record with no posted results; the study design and planned endpoints are documented but outcome data are not yet reported.
Reported
Planned enrollment358
Study phasePhase 3
Primary outcome measure 1Major Pathological Response (MPR) - IASLC M…